|
Ever Supreme Bio Technology Co., Ltd is a regenerative medicine company focused on the research and development of stem cell and cancer immunotherapy drugs. The company develops cell-based therapeutics through a patented technology platform, with key products including CAR001, a CAR-T therapy for solid tumors that has completed Phase I safety validation and entered Phase IIa clinical trials, and EXO-001. Its operations involve clinical trials and the production of cell preparations, targeting the global market for precision medicine and advanced cancer treatments. The company collaborates with international medical institutions, including Mayo Clinic, and participates in major biotechnology exhibitions to showcase its R&D progress. Summarised from the company's own disclosures |
Industry Biotechnology | Homepage ever-supreme.com.tw |
| Sector Healthcare | IR page — | |
|
Tags
regenerative medicine, stem cell therapy, cancer immunotherapy, car-t therapy, cell-based therapeutics, precision medicine, clinical trials, CAR001, EXO-001
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | NT$ 13.667B |
| Market cap (USD) | $ 414.825M |
| P/E | 28.45 |
| PEG | 0.99 |
| P/BV | 4.69 |
| P/S | 11.99 |
| P/OCF | 31.04 |
| P/FCF | — |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 25.9% |
| ROI | 28.1% |
| ROIC | 23.6% |
| Profit margin | 42.2% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | 28.9% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 12.5% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.018B | 933.813M | 758.391M | 627.512M | 438.841M | 70.597M | 10.819M | 0 | — |
| Net profit | 429.432M | 367.251M | 539.397M | 200.714M | 369.601M | -106.829M | -94.219M | -68.771M | -30.602M |
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Share price | 164 | — | — | — | — | — | — | — | — |
| P/S | 14.12 | — | — | — | — | — | — | — | — |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial information published on MOPS, newest first, subjects as filed in Chinese, guarantee and loan balance notices and routine equipment purchases included. The link opens the company's material information on MOPS. Press releases from the company's own website, newest first.
【2026長海盃路跑熱力登場!長聖生技、中亞聯大暨醫療體系與各衍生企業超過6,000人為愛、為健康、為幸福而跑】
「2026長海盃路跑」 由中國醫藥大學附設醫院主辦,中醫大及亞大暨醫療體系與衍生企業共同協辦,吸引超過6,000名同仁與眷屬熱情參與,共同展現跨機構團隊凝聚力與健康活力!
中國醫藥大學暨醫療體系董事長、亞洲大學暨醫療體系創辦人蔡長海親自帶領各機構領導團隊、同仁及家屬共襄盛舉,傳遞「愛、健康、幸福」的活動理念。
蔡長海董事長表示,體系中的醫療同仁平時忙於照顧病人,也希望大家在照顧別人的同時,別忘了照顧自己,和家人一起養成規律運動的習慣,讓同仁與家屬有機會定期相聚、一起運動。
精彩開幕|音樂與活力交織
九天民俗技藝團以鼓陣及大旗演出揭開序幕,中醫大附醫交響樂團攜手28位護理師組成的活力啦啦隊及優秀歌手,共同演繹專為本次活動創作的《長海之歌》,展現醫療團隊的多元才華!
健康開跑|10K挑戰、3K健康同樂
知名有氧健身老師潘若迪帶領全場暖身,鼓勵大家走出戶外、養成運動習慣。活動設有10公里挑戰組及3公里健康組,讓同仁與眷屬一起享受運動樂趣。
親子嘉年華|歡樂不間斷
LINE FRIENDS人氣角色熊大、兔兔及莎莉驚喜現身!現場還有「元氣小英雄」健康闖關、創意彩繪區、14輛特色胖卡餐車及元氣補給站,讓活動充滿親子同樂的歡樂氣氛。
從守護病人健康,到關懷每位同仁
長聖生技持續重視員工身心健康與幸福職場,透過運動、藝術及多元交流,讓健康與幸福融入日常生活,也凝聚體系共同向前的力量。
為愛而跑、為健康而跑、為幸福而跑!











-
電話:04-2325-2888
-
地址:406040台中市北屯區經貿路一段360號7樓
Copyright © 長聖國際生技股份有限公司 All Rights Reserved. 網站製作:新視野網頁設計

Official Website

長聖生技拓展國際連結,強化與世界頂尖醫療機構的交流,此次由范揚政教授邀請梅約診所 (Mayo Clinic) Shauna Overgaard博士於9月29日蒞臨參訪。Overgaard博士現任梅約診所人工智慧策略與架構資深總監、AI驗證與治理計畫共同主任,致力於推動AI研究走向臨床應用。此次長聖劉銖淇董事長帶領團隊以創新研發技術的進度與發展做雙邊的深度交流,為長聖生技帶來兼具策略與實務的國際視野。



-
電話:04-2325-2888
-
地址:406040台中市北屯區經貿路一段360號7樓
Copyright © 長聖國際生技股份有限公司 All Rights Reserved. 網站製作:新視野網頁設計

Official Website

Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Ever Supreme Bio Technology Co., Ltd
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.03% | 7,663 | $ 33.11K | Nov 16, 2026 |
| DEXC | 0.01% | 8,399 | $ 37.066K | Nov 12, 2026 |
| DFEV | 0.01% | 38,000 | $ 167.7K | Nov 12, 2026 |
| DFEM | 0.00% | 64,993 | $ 286.825K | Nov 12, 2026 |
| DFSE | 0.00% | 3,579 | $ 15.795K | Nov 12, 2026 |
| DFAE | 0.00% | 36,961 | $ 163.115K | Nov 12, 2026 |
| DFAX | 0.00% | 34,238 | $ 151.098K | Nov 12, 2026 |
| AVEM | 0.00% | 11,000 | $ 47.529K | Nov 16, 2026 |






















































